Poster Abstract Session:
70. Latent TB Infection: Diagnosis and Treatment
Thursday, October 8, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

-

Tracks: HIV-STD-TB, Adult ID, Global ID

Presentations:
555
Alternative Definitions of Latent Tuberculosis Infection
Andrew Hill, PhD ; Rachel Yelk Woodruff, MPH ; Roque Miramontes, PA-C, MPH
556
The Utility of Interferon-Gamma Release Assays (IGRAs) for the Diagnosis of Mycobacterium Tuberculosis (Mtb) in Cancer Patients
Joumana Kmeid, MD ; Dimpy Shah, MD, MSPH, PhD ; Firas El Chaer, MD ; Ella Ariza-Heredia, MD ; Edward a. Graviss, PhD, MPH ; Victor E. Mulanovich, MD ; Roy Chemaly, MD, MPH
557
Operational challenges undermine WHO TB symptom screen in pregnant women
Akanksha Vaidya, B.S ; Sanjaykumar Tambe, MD ; Ramesh Bhosale, MD, PhD ; Vidya Mave, MD, MPH ; Jessica Elf, MPH ; Neeta Pradhan, MSc ; Neetal Nevrekar, MD ; Sandesh Patil, MD ; Anju Kagal, MD ; Samir Joshi, MS ; Ajay Chandanwale, MS ; Amita Gupta, MD, MHS ; Jyoti S. Mathad, MD
Posters
  • IDSA poster-pdf.pdf (948.1 kB)
  • 558
    Tuberculosis prevention opportunities in a large provider network in California, 20112012
    Pennan Barry, MD, MPH ; Katya Salcedo, MPH ; Teeb Al-Samarrai, MD, MPH ; Jonathan Blum, MD ; Jim Nomura, MD ; Jennifer Flood, MD, MPH ; Jeffrey Schapiro, MD
    559
    Risk Factors for Non-completion of Latent Tuberculosis Infection Therapy at an Urban Public Health Clinic
    Hillary Dunlevy, MD, MPH ; Kaylynn Aiona, MPH ; Will Eaton, BS ; Robert Belknap, MD ; Michelle Haas, MD
    Posters
  • ID week LTBI final.pdf (493.0 kB)
  • CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.